Modulation of immunostimulatory properties of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S045000, C536S023100

Reexamination Certificate

active

07851453

ABSTRACT:
The invention relates to the therapeutic use of oligonucleotides as immunostimulatory agents in immunotherapy applications. More particularly, the invention provides immunomers and an immunostimulatory oligonucleotides for use in methods for generating an immune response or for treating a patient in need of immunostimulation. The immunomers and an immunostimulatory oligonucleotides of the invention preferably comprise novel purines. The immunomers according to the invention further comprise at least two oligonucleotides linked at their 3′ ends, internucleoside linkages or functionalized nucleobase or sugar to a non-nucleotidic linker, at least one of the oligonucleotides being an immunomodulatory oligonucleotide and having an accessible 5′ end.

REFERENCES:
patent: 5126439 (1992-06-01), Rappaport
patent: 5149798 (1992-09-01), Agrawal et al.
patent: 5366878 (1994-11-01), Pederson et al.
patent: 5594121 (1997-01-01), Froehler et al.
patent: 5635377 (1997-06-01), Pederson et al.
patent: 5652355 (1997-07-01), Metelev et al.
patent: 5663153 (1997-09-01), Hutcherson et al.
patent: 5677437 (1997-10-01), Teng et al.
patent: 5912332 (1999-06-01), Agrawal et al.
patent: 6143881 (2000-11-01), Metelev et al.
patent: 6232463 (2001-05-01), Cook et al.
patent: 6346614 (2002-02-01), Metelev et al.
patent: 6444682 (2002-09-01), Simmonds et al.
patent: 7255868 (2007-08-01), Fearon et al.
patent: 2003/0004325 (2003-01-01), Cook et al.
patent: 2003/0199466 (2003-10-01), Fearon et al.
patent: 2004/0009933 (2004-01-01), Wise et al.
patent: 2004/0053880 (2004-03-01), Krieg
patent: 2004/0097719 (2004-05-01), Agrawal et al.
patent: 2004/0156825 (2004-08-01), Agrawal et al.
patent: 2006/0014713 (2006-01-01), Agrawal et al.
patent: 2006/0211641 (2006-09-01), Agrawal et al.
patent: WO 98/49288 (1998-11-01), None
patent: WO 01/12804 (2001-02-01), None
patent: PCT/US01/13682 (2001-04-01), None
patent: WO 01/55370 (2001-08-01), None
patent: PCT/US01/30137 (2001-09-01), None
patent: WO 02/26757 (2002-04-01), None
Kandimalla et al, PNAS 11(24): 14303-14308, 2003.
Kuramoto et al, Jpn. J. Cancer Res. 83:1128-1131, 1992; of record, C11.
Krieg et al, Nature 371:546-549, 1995; of record, C12.
Liang et al, J. Clin. Invest. 98:1119-1129, 1996; of record, C13.
Moldoveanu et al, Vaccine 16:1216-1224, 1998, of record, C14.
McCluskie and Davis, J. Immunol. 161:4463-4466, 1998; of record, C15.
Kandimalla et al, Bioconjugate Chem. 13, 966-974, 2002.
Kandimalla et al, Nucleic Acid Research vol. 31, No. 9, 2003.
Donnelly et al, Nature Medicine, 9(11):1354-1356, 2003.
DeGruijl et al; Nature Medicine, 5110: 1124-1125, 1999.
Bitton R. J., Current Opinion in Molecular Therapeutics 611: 17-26, 2004; Abstract only.
Weiner, J. Leukoc. Biol. 68: 455-463, 2000.
Krieg et al, Pharmacol. & Therap. 84: 113-120, 1999.
Ballas et al, J. Immunol. 167: 4878-4886, 2001.
Agrawal et al, Trends in Molecular Medicine 813: 114-120, 2002.
Liu et al, J. Mol. Biol. 308(3):465-475, 2001.
Uhlmann et al.; Antisense Oligonucleotides: A New Therapeutic Principle, 90 (4): 543-584 (1990), Chemical Reviews.
Yu et al., “Immunomers'-Novel 3′-3′-Linked CpG Oligodeoxyribonucleotides as Potent Immunomodulatory Agents”, Nucleic Acids Res., 30(20):4460-4469 (2002).
Bhagat et al., “CpG Penta- and Hexadeoxyribonucleotides as Potent Immunomodulatory Agents”, Biochem. Biophys. Res. Comm., 300(4):853-861 (2003).
Yu et al., “Requirement of Nucleobase Proximal to CpG Dinucleotide for Immunostimulatory Activity of Synthetic CpD DNA”, Bioorg. & Med. Chem., 11(3):459-464 (2003).
Agrawal et al., Meth. in Mol. Biol., “Protocols for Oligonucleotides and Analogs”, 20:165-189, (1993).
Oligonucleotides and Analogues, A Practical approach, 87-108 (F. Eckstein, ed., 1991).
Uhlmann et al., Curr. Op. In Biotech., 6:12 (1995).
Crooke et al., Antisense Research and Applications, eds., CRC Press, Boca Raton, (1993).
Khorana et al., J. Mol. Bio., 72:209 (1972).Reese, Tetrahedron lett., 34:3143-3179 (1978).
Beaucage et al., Tetrahedron lett., 22:1859-1862 (1981).
Agrawal et al., Tetrahedron lett., 28:3539-3542 (1987).
Connolly et al., Biochem., 23:3443 (1984).
Jager et al., Biochem., 27:7237 (1988).
Agrawal et al., Proc. Natl. Acad. Sci. (USA), 85:7079-7082 (1988).
Kuramoto et al., Jpn. J. Cancer Res., 83:1128-1131 (1992).
Krieg et al., nature, 371:546-549 (1995).
Liang et al., J. Clin. Invest., 98:1119-1129 (1996).
Moldoveanu et al., Vaccine, 16:1216-124 (1998).
McCluskie et al., J. Immunol., 161:4463-4466 (1998).
Hartman et al., J. Immunol., 164:1617-1624 (2000).
Zhao et al., Biocehm. Pharmacol., 51:173-182 (1996).
Zhao et al., Biochem. Pharmacol., 52:1537-1544 (1996).
Zhao et al., Antisense Nucleic Acid Drug Dev., 7:495-502 (1997).
Zhao et al., Bioorg. Med. Chem. Lett., 9:3453-3458 (1999).
Zhao et al., Bioorg. Med. Chem. Lett., 10:1051-1054 (2000).
Yu et al., Bioorg. Med. Chem. Lett., 10:2585-2588 (2000).
Yu et al., Bioorg. Med. Chem. Lett., 11:2263-2267 (2001).
Kandimalla et al., Bioorg. Med. Chem., 9:807-813 (2001).
Remington's Pharmaceutical Sciences, 18th Ed., A. Gennaro, Mack Publishing Co. (1990).
Noronha et al., Biocehm., 39:7050-7062 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Modulation of immunostimulatory properties of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of immunostimulatory properties of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of immunostimulatory properties of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4210839

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.